Donate to the Samuel Rahbar Chair in Diabetes & Drug Discovery

Samuel Rahbar, M.D., Ph.D., dedicated his career to researching the causes and treatments of diabetes and cancer.  His seminal discovery involving glycated hemoglobin revolutionized the way diabetes is diagnosed and treated, and this continues to improve the lives of millions of diabetic patients throughout the world.  His later work exploring the metabolic link between cancer and diabetes has opened promising new doors for the development of drugs and treatments.
 
Your support today will enhance Dr. Rahbar’s legacy and allow City of Hope to continue its research into new therapies and treatments for patients everywhere suffering from these life-threatening diseases.

Please make your contribution today.
 
 
A letter from Michael A. Friedman, Chief Executive Officer
 
October 14, 2013
 
Dear Friend,
 
I am writing to tell you about a very meaningful initiative to honor the life and legacy of renowned scientist Dr. Samuel Rahbar. 
 
As you know, Dr. Rahbar’s research fundamentally transformed our understanding of diabetes and dramatically improved the lives of people everywhere with the disease. We at City of Hope want to recognize Dr. Rahbar’s many extraordinary contributions to science and continue his life-saving research by establishing the Samuel Rahbar Chair in Diabetes & Drug Discovery. His area of research bridges across both diabetes and cancer and has the potential to develop into new and better treatments for each of these serious diseases.
 
The Samuel Rahbar Chair in Diabetes & Drug Discovery will be a permanent, endowed position at City of Hope that will perpetuate Dr. Rahbar’s legacy, and honor his life and research for generations to come. An endowed chair is the highest honor an institution can award to a member of its faculty. By investing the endowment, the chair exists in perpetuity and is held by a succession of accomplished men and women in science and medicine. The Samuel Rahbar Chair in Diabetes & Drug Discovery will always exist at City of Hope, and it will serve as a lasting reminder of Dr. Rahbar’s remarkable achievements.
 
Dr. Rahbar was an inspiration to so many people, and I have such profound respect for him, both personally and as a scientist. I hope you will join us to create this permanent recognition of his remarkable achievements, and establish the Samuel Rahbar Chair in Diabetes & Drug Discovery to continue this important research.
 
Warmest regards,
 
Michael A. Friedman, M.D.
Chief Executive Officer
Director, Comprehensive Cancer Center
Irell & Manella Cancer Center Director’s Distinguished Chair
 
 
A Letter from the Rahbar Family

Dear family and friends,
 
Ever since our father, Professor Samuel Rahbar passed away last November, we have been trying to find a means of continuing his significant work.  We feel that the best way to honor his memory is to assure the work that he loved and put all his effort into continues. The people who worked with him and know the value of his research also would like to see this happen.
 
After our dad’s passing we met with Dr. Friedman, CEO of City of Hope Medical Center and Dr. Riggs, Chair of the Department of Diabetes and Metabolic Diseases at City of Hope.  They voiced their interest in setting up an endowed chair in our father’s name. Soon after the meeting we received a letter from Dr. Friedman reaffirming his interest in creating the endowed chair for our father.  With the help of the City of Hope writers, we have prepared an article soon to be published in several magazines about this project.
 
This initiative, “The Samuel Rahbar Chair in Diabetes and Drug Discovery,” will be a permanent, endowed position at City of Hope that will perpetuate our father's legacy, and honor his life and research for generations to come. An endowed chair is the highest honor an institution can award to a member of its faculty. As Dr. Friedman noted, the chair will serve as a lasting reminder of our father's remarkable achievements.
 
Even though our father will always be remembered for discovering the connection between HbA1c and diabetes, the compounds he synthesized in the last few years of his life have shown great promise as a potential treatment for a variety of cancers. The most promising is called COH-SR4. He submitted the paper on the effects of COH-SR4 on cancer cells the week before his death. The work continues on these compounds at City of Hope.  With this endowed chair, his research will hopefully come to fruition in the developments of treatments for cancer.
 
We are asking for your moral, emotional and financial support to establish “The Samuel Rahbar Chair in Diabetes and Drug Discovery.” Please contact us and pledge your support for this project.
 
Contact Roya Rahbar Pouldar at (310) 483-8853 ([email protected]); Guita Rahbar Fouladian at (310) 628-9703 ([email protected]); or Firoozeh Rahbar Bakshian at (310) 800-0788 ([email protected])
 
Regards,
 
Roya, Guita and Firoozeh Rahbar